alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 05-6851
UNITED STATES OF AMERICA, Plaintiff - Appellee, versus KENT GRIFFIN, Defendant - Appellant. Appeal from the United States District Court for the Eastern District of Virginia, at Newport News. Robert G. Doumar, Senior District Judge. (CR-01-26) Submitted: October 18, 2005 Decided: October 21, 2005 Before WIDENER, MICHAEL, and DUNCAN, Circuit Judges. Affirmed by unpublished per curiam opinion. Kent Griffin, Appellant Pro Se. Timothy Richard Murphy, Special Assistant United States Attorney, Newport News, Virginia, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).- 2 - PER CURIAM: Kent Griffin appeals the district court’s order denying his motion under the All Writs Act. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. See United States v. Griffin , No. CR-01-26 (E.D. Va. filed May 13, 2005 & entered May 16, 2005). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In  connection  with the Quarterly  Report of In Vivo Medical  Diagnostics,
Inc. (the  "Company") on Form 10-QSB/A for the quarter ended October 31, 2004 as
filed with the  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"),  I, Bernard Turner, Chief Financial Officer of the Company,  certify,
pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

          (1) The Report fully complies with the  requirements  of section 13(a)
     or 15(d) of the Securities and Exchange Act of 1934; and

          (2) The information  contained in the Report fairly  presents,  in all
     material respects,  the financial condition and result of operations of the
     Company.

     A signed  original of this  written  statement  required by Section 906 has
been  provided to In Vivo Medical  Diagnostics,  Inc. and will be retained by In
Vivo Medical  Diagnostics,  Inc. and  furnished to the  Securities  and Exchange
Commission or its staff upon request.


March 17, 2005                                       /s/ Bernard Turner
                                                     ---------------------------
                                                     Bernard Turner
                                                     Chief Financial Officer
II

104TH CONGRESS

1ST SESSION S. 1454

To authorize the Secretary of Transportation to issue a certificate of documentation with appropriate endorsement for employment in the coastwise

trade and fisheries for the vessel JOAN MARIE, and for other purposes.

IN THE SENATE OF THE UNITED STATES

DECEMBER 7, 1995

Mr. HELMS introduced the following bill; which was read twice and referred

to the Committee on Commerce, Science, and Transportation

A BILL

To authorize the Secretary of Transportation to issue a

certificate of documentation with appropriate endorsement for employment in the coastwise trade and fisheries

for the vessel JOAN MARIE, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. CERTIFICATE OF DOCUMENTATION.

4 Notwithstanding section 27 of the Merchant Marine

5 Act, 1920 (46 U.S.C. App. 883), section 8 of the Act of

6 June 19, 1886 (24 Stat. 81, chapter 421; 46 U.S.C. App.

7 289), and sections 12106 and 12108 of title 46, United

8 States Code, the Secretary of Transportation may issue
2

•S 1454 IS

1 a certificate of documentation with appropriate endorse2 ment for employment in the coastwise trade and fisheries

3 for the vessel JOAN MARIE, State of North Carolina offi4 cial number NC2319AV.

Æ
[Federal Register Volume 89, Number 11 (Wednesday, January 17, 2024)]
[Rules and Regulations]
[Page 2885]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00708]


=======================================================================
-----------------------------------------------------------------------

FEDERAL COMMUNICATIONS COMMISSION

47 CFR Part 10

[PS Docket Nos. 15-94; 15-91; FCC 23-88; FR ID 196695]


Emergency Alert System; Wireless Emergency Alerts; Correction

AGENCY: Federal Communications Commission.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: This document corrects the DATES section of a final rule that 
appeared in the Federal Register on December 15, 2023, regarding the 
Wireless Emergency Alert system. This correction adds to the list of 
rules sections with indefinitely delayed effective dates.


DATES: The correction is effective on January 17, 2024.

FOR FURTHER INFORMATION CONTACT: For further information regarding this 
final rule correction, please contact Michael Antonino, Cybersecurity 
and Communications Reliability Division, Public Safety and Homeland 
Security Bureau, (202) 418-7965, or by email to 
<a href="/cdn-cgi/l/email-protection#5835313b30393d347639362c3736313637183e3b3b763f372e"><span class="__cf_email__" data-cfemail="1875717b70797d743679766c7776717677587e7b7b367f776e">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The Commission is correcting the DATES 
section of final rule FR Doc. 2023-27236 by adding rule 47 CFR 
10.210(a) to the list of rules sections whose effective dates are 
delayed indefinitely.

Correction

    In FR Rule Doc. 2023-27236, appearing on page 86824 in the Federal 
Register of December 15, 2023, on page 86824, in the first column, the 
DATES section is corrected to read:

DATES: Effective December 15, 2026, except for the amendments to 47 CFR 
10.210(a), (b), (c), and (d), 10.350(d), 10.480(a) and (b), and 
10.500(e), which are delayed indefinitely. The Federal Communications 
Commission will announce the effective dates of the delayed amendments 
by publishing documents in the Federal Register.

Federal Communications Commission.
Marlene Dortch,
Secretary.
[FR Doc. 2024-00708 Filed 1-16-24; 8:45 am]
BILLING CODE 6712-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
THIS OPINION HAS NO PRECEDENTIAL VALUE. IT SHOULD NOT BE 

CITED OR RELIED ON AS PRECEDENT IN ANY PROCEEDING 

EXCEPT AS PROVIDED BY RULE 268(d)(2), SCACR. 

THE STATE OF SOUTH CAROLINA 

In The Supreme Court 

Sylvester Toomer, Petitioner, 

v. 

State of South Carolina, Respondent. 

Appellate Case No. 2011-192933 

ON WRIT OF CERTIORARI 

Appeal from Jasper County 

Perry M Buckner, III, Trial Judge 

D. Craig Brown, Post-Conviction Relief Judge 

Memorandum Opinion No. 2013-MO-032 

Submitted July 25, 2013 – Filed October 30, 2013 

AFFIRMED 

Deputy Chief Appellate Defender Wanda H. Carter, of 

Columbia, for Petitioner. 

Attorney General Alan M. Wilson and Assistant Attorney 

General Ashleigh R. Wilson, of Columbia, for 

Respondent. 
 PER CURIAM: This Court granted certiorari to review Sylvester Toomer's 

conviction through a belated appeal pursuant to White v. State, 263 S.C. 110, 208 

S.E.2d 35 (1974). Toomer argues the trial court erred in allowing the State to 

reference the September 11, 2001 terrorist attacks in its closing argument. 

Although he acknowledges he did not object to the statements, he contends the 

nature of the statements were so clearly prejudicial that the Court should disregard 

the rules of preservation and grant him a new trial. We disagree and affirm 

pursuant to Rule 220(b)(1), SCACR, and the following authorities: State v. 

Sheppard, 391 S.C. 415, 420–21, 706 S.E.2d 16, 19 (2011) ("Our law is clear that 

a party must make a contemporaneous objection that is ruled upon by the trial 

judge to preserve an issue for appellate review."); Toyota of Florence, Inc. v. 

Lynch, 314 S.C. 257, 263, 442 S.E.2d 611, 615 (1994) (holding the vicious and 

inflammatory use of racial prejudice in counsel's closing argument resulted in clear 

prejudice such that the appellant was entitled to a new trial); S.C. State Highway 

Dep't v. Nasim, 255 S.C. 406, 411–12, 179 S.E.2d 211, 213 (1971) (finding 

counsel's "vicious" use of "abusive epithets" against an adverse witness warranted 

the grant of a new trial); cf. Vasquez v. State, 388 S.C. 447, 460, 698 S.E.2d 561, 

567 (2010) (finding defense counsel's failure to object was prejudicial where 

solicitor unnecessarily injected religious prejudice into the trial by describing the 

Muslim defendant as a "domestic terrorist" and comparing the charged crimes to 

the attacks on September 11, 2001); State v. Jones, 320 S.C. 555, 558, 466 S.E.2d 

733, 734 (Ct. App. 1996) (noting that for error to be reversible, "improper 

statements must materially prejudice the right of the defendant to obtain a fair and 

impartial trial"). 

AFFIRMED. 

TOAL, C.J., PLEICONES, BEATTY, KITTREDGE and HEARN, JJ., 

concur.
## IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

NO S

. PD

- 0347

- 20 & PD

- 0348

- 20

RICHARD LEE PERCIVILL

, JR., App ellant

v.

THE STATE OF TEXAS

ON STATE’S PETITION FOR DISCRETIONARY REVIEW

FROM THE SIXTH COURT OF APPEALS

GREGG COUNTY

Y EARY , J., filed a dissenting opinion in which S LAUGHTER , J., joined

.

DISSENTING OPINION

For the reasons set out in my dissenting opinion in Dulin v. State , ___ S.W.3d ___,

No s . PD

- 0856

- 19 & PD

- 1857

- 19 , 2021 WL 1202400 (Tex. Crim. App. Mar. 31, 2021), I

respectfully dissent to the Court’s disposition of the State’s petition for discretionary

review.

FIL ED: May 12, 2021

DO NOT PUBLISH
INITIAL REVIEW ENGINEERING REPORT

P-14-0042

Focus Ready Draft 12/30/2013

ENGINEER: Choudhary \ JAS

PV (kg/yr): 

Revision Notes/Assessment Overview:

SUBMITTER:

USE:

OTHER USES:

MSDS: No LABEL: No

CRSS: (12/19/2013):

Chemical Name: 

S-H2O: Dispersible g/L @ 

VP: 1.0E-6 torr @ 

MW: 

Physical State and Misc CRSS Info:

 

 

Consumer Use:

SAT (concerns): (12/20/2013):

Related Cases and Misc SAT Info:

Analogs: 

Migration to groundwater: Other (please specify)

PBT rating: P3 B3 T1 // PMN: P3B1T1 // Deg Pdt: P3B3T1.

Health:

Eco: 

OCCUPATIONAL EXPOSURE RATING:

NOTES & KEY ASSUMPTIONS:

Generated by the 09/30/2013 version of ChemSTEER.

EPA SANITIZED Page 1 of 6
 

POLLUTION PREVENTION CONSIDERATIONS:

P2 REC:

 

 

 

EPA SANITIZED Page 2 of 6
P-14-0042

Manufacturing

Number of Sites/Location: 

Basis: 

Process Description: 

ENVIRONMENTAL RELEASES ESTIMATE SUMMARY

Conservative: 

to: 

from: 

RELEASE TOTAL

OCCUPATIONAL EXPOSURES ESTIMATE SUMMARY

Tot. # of workers exposed via assessed routes: 

Basis: 

Dermal:

High End: 

Number of workers (all sites) with Dermal exposure:

Basis: 

EPA SANITIZED Page 3 of 6
P-14-0042

Processing: 

Number of Sites/Location:

Basis: 

Process Description: 

ENVIRONMENTAL RELEASES ESTIMATE SUMMARY

RA Boiler and Industrial Furnace Rule, which requires a minimum of 99.99% 

combustion efficiency.

Conservative: 

to: 

from: 

RELEASE TOTAL

OCCUPATIONAL EXPOSURES ESTIMATE SUMMARY

Tot. # of workers exposed via assessed routes: 

Basis: 

Dermal:

High End: 

Number of workers (all sites) with Dermal exposure:

Basis: 

EPA SANITIZED Page 4 of 6
P-14-0042

Use 

Number of Sites/Location:

Basis: 

Process Description: 

ENVIRONMENTAL RELEASES ESTIMATE SUMMARY

Output 2: 

to: 

from: 

basis: 

RELEASE TOTAL

OCCUPATIONAL EXPOSURES ESTIMATE SUMMARY

Tot. # of workers exposed via assessed routes: 

Basis: 

Dermal:

High End: 

Number of workers (all sites) with Dermal exposure:

Basis: 

EPA SANITIZED Page 5 of 6
P-14-0042

Use 

Number of Sites/Location: 

 

Basis: 

Process Description: 

ENVIRONMENTAL RELEASES ESTIMATE SUMMARY

Output 2: 

to: 

from: 

basis: 

RELEASE TOTAL

OCCUPATIONAL EXPOSURES ESTIMATE SUMMARY

Tot. # of workers exposed via assessed routes: 

Basis: 

Dermal:

High End: 

Number of workers (all sites) with Dermal exposure:

Basis: 

EPA SANITIZED Page 6 of 6
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

DENIS CHAVEZ

, Appellant,

v.

STATE OF FLORIDA

, Appellee

.

No. 4D 19

- 2902

[ November 27, 2019 ]

Appeal of order denying rule 3.800 motion from the Circuit Court for

the Seventeenth Judicial Circuit, Broward County ; Elizabeth Anne

Scherer , Judge; L.T. Case No. 03

- 8048 CF10A

.

Denis Chavez, Miami, pro se.

No appearance required for appellee.

P ER C URIAM

.

Affirmed.

T

AYLOR

, M AY and C ONNER

, J J., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
Letter Agreement



 EXHIBIT 10.2 
 February 2, 2012 
 Steven B. Ketchum 
 49 Canoe Brook Lane 
 Far Hills, NJ 07931-2808 

 

	Re:	Change of Status 

 Dear Steve: 

This letter confirms that you have tendered your resignation to the Company, effective February 15, 2012, and the Company hereby accepts that
resignation effective that day. You acknowledge and agree that you are not entitled to any severance benefits from the Company arising from your resignation of employment. 
 The Board of Directors has approved your appointment to the Board, effective as of February 15, 2012. In that role, you will be eligible for the standard Board retainer of $30,000 per year, payable
on the date of our annual stockholders’ meeting (typically held in June). You currently have four option grants, all of which shall continue to vest until June 30, 2012 (or earlier if your Board service ends prior to that date). You hereby
agree that all stock options held by you that do not vest on or before June 30, 2012 shall be forfeited by you. Your vested stock options will remain exercisable during your Board service in accordance with the terms of the applicable stock
option agreements. In your capacity as a Board member, you will remain eligible for periodic equity grants as determined by the Board in its sole discretion. 
 The Board has also approved a bonus payment to you in accordance with the Company’s 2011 Bonus Program in the amount of $95,700, less standard payroll deductions and withholdings. The bonus payment
shall be made concurrently with payments to other participants in the 2011 Bonus Program, which is expected to occur in the first quarter of 2012. 
 We appreciate your service to the Company, and look forward to working with you in your new role as a Director. 
  

	
	Best regards,
	
	/s/ Daniel N. Swisher, Jr.
	Daniel N. Swisher, Jr.
	President and Chief Executive Officer

  

					
	ACCEPTED AND AGREED TO:	 		 	
			
	/s/ Steven B. Ketchum	 		 	February 2, 2012
	Steven B. Ketchum	 		 	Date
<PAGE>   1
 
   
                                                                    EXHIBIT 23.4
    
 
   
                         INDEPENDENT AUDITORS' CONSENT
    
 
   
The Board of Directors
    
   
UROHEALTH Systems, Inc.:
    
 
   
We consent to incorporation by reference in the Registration Statement (No.
333-12723) on Form S-3 of our report dated October 10, 1995, relating to the
consolidated balance sheet of Dacomed Corporation as of June 24, 1995 and the
related consolidated statements of operations, stockholders' equity and cash
flows for the fiscal year then ended, and our report dated December 19, 1994,
relating to the consolidated statements of operations, stockholders' equity and
cash flows for Dacomed Corporation for the fiscal year ended October 29, 1994
and to the reference to our Firm under the heading "Experts" in the Registration
Statement.
    
 
   
                                          /s/  KPMG PEAT MARWICK LLP
    
 
                                          --------------------------------------
   
                                               KPMG Peat Marwick LLP
    
   
Minneapolis, Minnesota
    
   
November 6, 1996
<PAGE>

                                  Exhibit 23.1

                               Consent of KPMG LLP



<PAGE>

                          Independent Auditors' Consent

The Board of Directors
CollaGenex Pharmaceuticals, Inc.:

We consent to the incorporation by reference in the registration statements
(No. 333-31229 and No. 333-73230) on Form S-8 and (No. 333-88697, No. 333-35634,
No. 333-53766, No. 333-58568, No. 333-67044, No. 333-72166, No. 333-87556,
No. 333-102773 and No. 333-103008) on Form S-3 of CollaGenex Pharmaceuticals,
Inc. of our report dated February 14, 2003, except as to the first paragraph
of note 15 which is as of March 14, 2003 and the second and third paragraphs of
note 15 which are as of March 18, 2003, with respect to the consolidated
balance sheets of CollaGenex Pharmaceuticals, Inc. and subsidiaries as of
December 31, 2002 and 2001, and the related consolidated statements of
operations, stockholders' equity and cash flows for each of the years in
the three-year period ended December 31, 2002, and the related financial
statement schedule, for each of the years in the three-year period ended
December 31, 2002, which report appears in the December 31, 2002 Annual
Report on Form 10-K of CollaGenex Pharmaceuticals, Inc. Our report refers to
the Company's adoption of the provisions of the Securities and Exchange
Commission's Staff Accounting Bulletin No. 101, "Revenue Recognition in
Financial Statements", in 2000.

                                                 /s/ KPMG LLP

Princeton, New Jersey
March 31, 2003
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1634 Referred in House (RFH)]

104th CONGRESS
  2d Session
                                S. 1634

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 10, 1996

                 Referred to the Committee on Resources

_______________________________________________________________________

                                 AN ACT

 
  To amend the resolution establishing the Franklin Delano Roosevelt 
     Memorial Commission to extend the service of certain members.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled, 
That the first section of the Act entitled ``An Act to establish a 
commission to formulate plans for a memorial to Franklin Delano 
Roosevelt'', approved August 11, 1955 (69 Stat. 694) is amended by 
adding at the end thereof the following: ``A Commissioner who ceases to 
be a Member of the Senate or the House of Representatives may, with the 
approval of the appointing authority, continue to serve as a 
Commissioner for a period of up to one year after he or she ceases to 
be a Member of the Senate or the House of Representatives.''.

            Passed the Senate June 6, 1996.

            Attest:

                                             KELLY D. JOHNSTON,

                                                             Secretary.
```
EXHIBIT
      32


CERTIFICATION
      PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002


(18
      U.S.C. SECTION 1350)








Pursuant
      to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of
      the
      registrant certifies, to the best of his knowledge, that the registrant's
      Quarterly Report on Form 10-QSB for the period ended September 30, 2006 (the "Form
      10-QSB") fully complies with the requirements of Section 13(a) or 15(d) of
      the
      Securities Exchange Act of 1934 and that the information contained in the Form
      10-QSB, fairly presents, in all material respects, the financial condition
      and
      results of operations of the registrant.





Date:
                May 21, 2007Amanasu
                Environment Corporation/s/
                Atsushi MakiAtsushi
                MakiCEO,
                CFO, CAO
S. 1577

One Hundred Fourth Congress

of the

United States of America

AT THE SECOND SESSION

Begun and held at the City of Washington on Wednesday,

the third day of January, one thousand nine hundred and ninety-six

An Act

To authorize appropriations for the National Historical Publications and Records

Commission for fiscal years 1998, 1999, 2000, and 2001.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. AUTHORIZATION OF APPROPRIATIONS FOR THE NATIONAL

HISTORICAL PUBLICATIONS AND RECORDS COMMISSION.

Section 2504(f)(1) of title 44, United States Code, is amended—

(1) in subparagraph (F) by striking out ‘‘and’’ after the

semicolon;

(2) in subparagraph (G) by striking out the period and

inserting in lieu thereof a semicolon; and

(3) by adding at the end the following new subparagraphs: ‘‘(H) $10,000,000 for fiscal year 1998;

‘‘(I) $10,000,000 for fiscal year 1999;

‘‘(J) $10,000,000 for fiscal year 2000; and

‘‘(K) $10,000,000 for fiscal year 2001.’’.

Speaker of the House of Representatives.

Vice President of the United States and

President of the Senate.
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
        (SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
                               UNITED STATES CODE)


Pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002 (subsections (a) and
(b) of Section 1350,  Chapter 63 of Title 18,  United States Code),  each of the
undersigned  officers of Wien Group, Inc., a New York corporation (the Company),
do hereby  certify with respect to the  Quarterly  Report of the Company on Form
10-QSB for the quarter ended  December 31, 2003, as filed with the  Securities &
Exchange Commission (the 10-QSB Report) that:

         (1)      the 10-QSB  Report fully  complies  with the  requirements  of
                  sections  13(a) and 15(d) of the  Securities  Exchange  Act of
                  1934; and,

         (2)      the   information   contained  in  the  10-QSB  Report  fairly
                  presents,  in all material respects,  the financial  condition
                  and results of operations of the Company.

A signed  original of this  written  statement  required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.

Dated: February 12, 2004                        /S/ STEPHEN S. WIEN
                                                --------------------------------
                                                STEPHEN S. WIEN
                                                Chief Executive Officer &
                                                Chief Financial Officer